Product Name: EIF2S1 (46-57)
Product Number: PE-01ACR95
Size: 200 µg      Price:42.00
1 mg      $US83.00
Peptide Name: EIF2S1 (46-57)

Product Use: For assaying the phosphotransferase activities of MAP kinase-interacting serine-threonine kinase 1 (MNK1, UniProt ID Q9BUB5), Interferon-induced, double-stranded RNA-activated protein kinase (EIF2AK2, UniProt ID P19525), Eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3, UniProt ID Q9NZJ5), and Eukaryotic translation initiation factor 2-alpha kinase 4 (EIF2AK4 (GCN2), UniProt ID Q9P2K8).

Peptide Production Method: Solid-phase peptide synthesis

Peptide Origin: Based on EIF2S1 phosphosite

Peptide Sequence: CILLSELSRRRIR

Peptide Modifications N Terminus: Free amino

Peptide Modifications C Terminus: Free carboxyl
Peptide Molecular Mass Calculated: 1614.99 Da

Peptide Purity Percent after Synthesis and Purification: >95

Peptide Appearance: White powder

Peptide Form: Solid

Storage Conditions: -20°C

Peptide Recommended Enzyme: MNK1; EIF2AK2; EIF2AK3; EIF2AK4 (GCN2)

Scientific Background: EIF2S1 mediates early steps in protein synthesis by forming a ternary complex with GTP and initiator tRNA. This complex subsequently binds to a 40S ribosomal subunit, followed by mRNA binding to form a 43S preinitiation complex. Junction of the 60S ribosomal subunit to form the 80S initiation complex is preceded by hydrolysis of the GTP bound to eIF-2 and release of an eIF-2-GDP binary complex. For eIF-2 to recycle and catalyze another round of initiation, the GDP bound to eIF-2 must exchange with GTP by way of a reaction catalyzed by eIF-2B.